search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ANALYTICAL & LABORATORY EQUIPMENT


SpeciSafe secondary packaging incorporates an ultra-absorbent lining and tube separation for convenient compliance


SUPERIOR SAMPLE TRANSPORT


Sue Fletcher explains how to ensure that your biological samples are packaged correctly


T


he Covid-19 pandemic has increased awareness of the importance of correct packaging of biological specimens for


transport by courier or mail, from the patient source to clinics and laboratories, for centralised testing or clinical trials. Designated as dangerous goods, diagnostic samples for Covid-19 are classifi ed as Category B (UN3373). T ere are strict regulations governing how such samples are packaged for transport (Packaging Instruction P650), and it is vital that all staff understand the legislation and how to be fully compliant. If not, there could be serious consequences, even leading to prosecution. Non-compliance can mean risk of infection, additional workload for clean ups and re-tests and delays in


Basic UN3373 packaging requirements


diagnosis. For the laboratory packaging the sample there could be fi nes or even imprisonment. Laboratory personnel are trained to handle human or animal samples correctly, to keep themselves and others safe. But, when it comes to sample transport the legislation can be diffi cult to interpret and costly to implement, both in terms of time and money. When samples are being sent as


‘Category B’, the packaging must meet certain minimum conditions. Principally it must consist of three components: the leak proof primary receptacle (blood tube/universal container/swab tube); a secondary packaging (e.g. sealed plastic bag or rigid container); plus an outer packaging (cardboard box or mailing envelope). When sending multiple tubes they must be separated. T e primary or secondary packaging must withstand the 95kPa pressure test, and the entire package, with its three layers, must withstand a 1.2m drop test without any damage to the primary container. In addition, there must also be suffi cient absorbent material included in the package to absorb all of the sample volume (special absorbent sheet, blue roll, foam, cotton wool etc.). Samples being sent under UN3373 Category B, Biological Substance should also display the appropriate symbol. T ere are additional stipulations and requirements particularly relating to air transport (IATA).


Trying to meet these requirements using standard materials can be a daunting task and lead to variability within the packaging processes, inadequate absorbency or excessive packaging (making the sample more expensive to mail). Ideally, DIY solutions should be avoided as there are specifi c tests regarding robustness, absorbency, etc. that elements of the packaging must comply with to be considered suitable. To help provide some packaging consistency there are a number of off -the- shelf materials readily available to assist with compliance. T e SpeciSafe range of secondary packaging from Alpha Laboratories is one example that provides a consistent, convenient and cost-eff ective means of compliance. T e robust, blister type, leak-proof pack combines an ultra-absorbent gel-based material within the rigid container. It simply encloses the sample container and protects it in the sealed casing. Similarly, the ShuttlePouch provides a convenient pouch for individual vials with absorbent material inside. A wide range of other sample transport packaging materials is also available, including absorbent sheets, 95kPa pouches, rigid boxes, envelopes and labels and complete kits for sample transport.


Sue Fletcher is with Alpha Laboratories. www.alphalabs.co.uk/un3373


www.scientistlive.com 17


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60